Jane Street’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-282,478
| Closed | -$360K | – | 10109 |
|
|
2023
Q3 | $360K | Buy |
+282,478
| New | +$247K | ﹤0.01% | 6775 |
|
|
2023
Q1 | – | Sell |
-38,984
| Closed | -$20.7K | – | 10298 |
|
|
2022
Q4 | $20.7K | Sell |
38,984
-24,231
| -38% | -$15.4K | ﹤0.01% | 8606 |
|
|
2022
Q3 | $46K | Buy |
+63,215
| New | +$71.7K | ﹤0.01% | 8969 |
|
|
2022
Q2 | – | Sell |
-63,346
| Closed | -$130K | – | 11293 |
|
|
2022
Q1 | $130K | Buy |
63,346
+18,541
| +41% | +$44.1K | ﹤0.01% | 9322 |
|
|
2021
Q4 | $129K | Sell |
44,805
-29,879
| -40% | -$111K | ﹤0.01% | 9099 |
|
|
2021
Q3 | $316K | Buy |
74,684
+49,185
| +193% | +$219K | ﹤0.01% | 8084 |
|
|
2021
Q2 | $136K | Sell |
25,499
-4,932
| -16% | -$23.7K | ﹤0.01% | 9108 |
|
|
2021
Q1 | $142K | Buy |
+30,431
| New | +$138K | ﹤0.01% | 8485 |
|
|
2020
Q3 | – | Sell |
-138,145
| Closed | -$466K | – | 8161 |
|
|
2020
Q2 | $466K | Buy |
+138,145
| New | +$653K | ﹤0.01% | 5189 |
|
|
2019
Q4 | – | Sell |
-11,352
| Closed | -$86K | – | 5950 |
|
|
2019
Q3 | $86K | Sell |
11,352
-6,653
| -37% | -$75K | ﹤0.01% | 4818 |
|
|
2019
Q2 | $244K | Buy |
+18,005
| New | +$208K | ﹤0.01% | 4468 |
|
|
2019
Q1 | – | Sell |
-12,267
| Closed | -$36K | – | 5819 |
|
|
2018
Q4 | $36K | Sell |
12,267
-23,288
| -65% | -$128K | ﹤0.01% | 4747 |
|
|
2018
Q3 | $290K | Buy |
35,555
+10,967
| +45% | +$84.2K | ﹤0.01% | 4249 |
|
|
2018
Q2 | $239K | Buy |
+24,588
| New | +$252K | ﹤0.01% | 4371 |
|
Jane Street's ZYNE Position: Q4 2023 in Review
Jane Street sold out of Zynerba Pharmaceuticals, Inc (ZYNE) in Q4 2023, closing a stake of 282,478 shares — an estimated $360K sold.
Jane Street first reported a position in ZYNE in Q2 2018 and held it in 14 quarters. The position peaked at $466K in Q2 2020. 0 funds tracked by Wall St. Rank hold ZYNE as of Q4 2023.
- Jane Street reported no remaining Zynerba Pharmaceuticals, Inc position as of Q4 2023 after selling out during the quarter.
- Jane Street sold 282,478 Zynerba Pharmaceuticals, Inc shares in Q4 2023, an estimated $360K.
- Jane Street first reported a position in Zynerba Pharmaceuticals, Inc in Q2 2018 and held it in 14 quarters.
- Jane Street's Zynerba Pharmaceuticals, Inc position peaked at $466K in Q2 2020.
- 0 funds tracked by Wall St. Rank held Zynerba Pharmaceuticals, Inc as of Q4 2023.
Based on Jane Street's 13F filing for Q4 2023, filed 15 Feb 2024.